Furthermore, by supporting weight loss and reducing fluid retention through natriuretic effects, GLP-1 RAs may reduce the burden on the myocardium, particularly in patients with underlying structural abnormalities common in adult congenital heart disease. The gene discussed is GCG; the disease is congenital heart disease.